Home
About
FAQ
History (5)
Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?
Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Laxatives
Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors.
Patient-Reported Outcomes and Reoperation Rates Following Lumbar Tubular Microdecompression: Six-year Follow-Up.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?
Veverka KK, Feldman SR. Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism? J Dermatolog Treat. 2018 Aug; 29(5):475-480.
View in:
PubMed
subject areas
Candidiasis, Chronic Mucocutaneous
Esophageal Neoplasms
Humans
Interleukin-17
Oropharyngeal Neoplasms
Prevalence
authors with profiles
Steven R. Feldman MD, PhD